Aurobindo Pharma's Unit Gets US FDA's Voluntary Action Indicated Classification; Shares Up 3%

MT Newswires Live

Mar 20

Aurobindo Pharma (NSE:AUROPHARMA, BOM:524804) said Unit-V of its wholly-owned subsidiary, Apitoria Pharma, has been classified as "voluntary action indicated" by the U.S. Food and Drug Administration (US FDA), according to a Friday filing to the Indian stock exchanges.

The US FDA inspected the facility, based in the Sangareddy district of Telangana, India, between Dec. 1, 2025, and Dec. 12, 2025.

At the end of the inspection, the regulator issued a 'Form 483' with three observations.

The unit has now received an establishment inspection report classifying the facility as 'voluntary action indicated', marking the inspection as closed.

The company's shares were up nearly 3% in recent trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2620767207"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620767207\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620767207?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-20 14:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620767207","market":"us","top_or_hot":-1,"title":"Aurobindo Pharma's Unit Gets US FDA's Voluntary Action Indicated Classification; Shares Up 3%","media":"MT Newswires Live","content":"<html><body><p> Aurobindo Pharma (NSE:AUROPHARMA, BOM:524804) said Unit-V of its wholly-owned subsidiary, Apitoria Pharma, has been classified as \"voluntary action indicated\" by the U.S. Food and Drug Administration (US FDA), according to a Friday filing to the Indian stock exchanges.</p><p>The US FDA inspected the facility, based in the Sangareddy district of Telangana, India, between Dec. 1, 2025, and Dec. 12, 2025.</p><p>At the end of the inspection, the regulator issued a 'Form 483' with three observations.</p><p>The unit has now received an establishment inspection report classifying the facility as 'voluntary action indicated', marking the inspection as closed.</p><p>The company's shares were up nearly 3% in recent trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aurobindo Pharma's Unit Gets US FDA's Voluntary Action Indicated Classification; Shares Up 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAurobindo Pharma's Unit Gets US FDA's Voluntary Action Indicated Classification; Shares Up 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-20 14:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Aurobindo Pharma (NSE:AUROPHARMA, BOM:524804) said Unit-V of its wholly-owned subsidiary, Apitoria Pharma, has been classified as \"voluntary action indicated\" by the U.S. Food and Drug Administration (US FDA), according to a Friday filing to the Indian stock exchanges.</p><p>The US FDA inspected the facility, based in the Sangareddy district of Telangana, India, between Dec. 1, 2025, and Dec. 12, 2025.</p><p>At the end of the inspection, the regulator issued a 'Form 483' with three observations.</p><p>The unit has now received an establishment inspection report classifying the facility as 'voluntary action indicated', marking the inspection as closed.</p><p>The company's shares were up nearly 3% in recent trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2620767207","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620767207","pubTimestamp":1773987572,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Aurobindo Pharma  said Unit-V of its wholly-owned subsidiary, Apitoria Pharma, has been classified as \"voluntary action indicated\" by the U.S. Food and Drug Administration , according to a Friday filing to the Indian stock exchanges.The US FDA inspected the facility, based in the Sangareddy district of Telangana, India, between Dec. 1, 2025, and Dec. 12, 2025.At the end of the inspection, the regulator issued a 'Form 483' with three observations.The unit has now received an establishment inspection report classifying the facility as 'voluntary action indicated', marking the inspection as closed.The company's shares were up nearly 3% in recent trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4588":"碎股","LABU":"三倍做多标普生物-Direxion"},"translate_title":"Aurobindo Pharma的部门获得美国FDA的自愿行动指示分类；股价上涨3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":1.5},"content_text":"Aurobindo Pharma (NSE:AUROPHARMA, BOM:524804) said Unit-V of its wholly-owned subsidiary, Apitoria Pharma, has been classified as \"voluntary action indicated\" by the U.S. Food and Drug Administration (US FDA), according to a Friday filing to the Indian stock exchanges.The US FDA inspected the facility, based in the Sangareddy district of Telangana, India, between Dec. 1, 2025, and Dec. 12, 2025.At the end of the inspection, the regulator issued a 'Form 483' with three observations.The unit has now received an establishment inspection report classifying the facility as 'voluntary action indicated', marking the inspection as closed.The company's shares were up nearly 3% in recent trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}